Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 766 (ZNF766) is a member of the C2H2-type zinc finger protein family and acts as a predicted DNA-binding transcription factor located in the nucleus[3][2][5]. It is involved in the regulation of transcription by RNA polymerase II, likely by binding to specific DNA sequences in promoter regions to influence gene expression[3][2][5][7]. No direct roles in disease, drug interactions, or established therapeutic targeting have been reported, and its biological function is not fully characterized. Like other zinc finger proteins, ZNF766 may contribute to gene regulatory networks involved in diverse physiological and potentially pathological processes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 766 (ZNF766).